Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma

Laboratory Investigation

Volumn 87, Issue 3, 2007, Pages 241-250

  Ko, Young Hyeh ^a,b,c   Park, Sanghui ^a   Jin, Heekyung ^b   Woo, Heesook ^a   Lee, Hyunseop ^a   Park, Chaewha ^a   Kim, Kihyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Apoptosis; Granzyme B; NK T cell lymphoma

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C; ENZYME INHIBITOR; GRANZYME B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; PROTEIN P85; PROTEINASE INHIBITOR 9; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOSOL; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NATURAL KILLER CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STAINING; T CELL LYMPHOMA; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; ENZYME INHIBITORS; GRANZYMES; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MICROSCOPY, ELECTRON; NOSE NEOPLASMS;

EID: 33847642636     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700517     Document Type: Article

References (26)

1. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours, Pathology & Genetics Tumours of the Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC) Press: Lyon, 2001, pp 214-215.
2. Lipford Jr EH, Margolick JB, Longo DL, et al. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988;72:1674-1681.
3. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90:4099-4105.
4. Ng CS, Lo ST, Chan JK. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Hum Pathol 1999;30:48-53.
5. Takakuwa T, Dong Z, Nakatsuka S, et al. Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene 2002;21:4702-4705.
6. Jeon YK, Kim H, Park SO, et al. Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma. Lab Invest 2005;85:874-884.
7. Taub DD, Sayers TJ, Carter CR, et al. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877-3888.
8. Lord SJ, Rajotte RV, Korbutt GS, et al. Granzyme B: a natural born killer. Immunol Rev 2003;193:31-38.
9. Cho MS, Lee MK, Yang WI, et al. Granzyme B immunoreactivity in T/natural killer cell lymphomas. Yonsei Med J 1997;38:285-293.
10. Sun J, Bird CH, Sutton V, et al. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem 1996;271:27802-27809.
11. Kagami Y, Nakamura S, Suzuki R, et al. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Br J Haematol 1998;103:669-677.
12. Robertson MJ, Cochran KJ, Cameron C, et al. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996;24:406-415.
13. Morales-Gonzalez JA, Gutierrez-Salinas J, Pina E. Release of mitochondrial rather than cytosolic enzymes during liver regeneration in ethanol-intoxicated rats. Arch Med Res 2004;35:263-270.
14. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
15. Jäättelä M, Leist M. From caspases to alternative cell-death mechanisms. In: Yin XM, Dong Z (eds). Essentials of apoptosis. A Guide for Basic and Clinical Research. Humana Press Inc.: New Jersey, 2003, pp 101-122.
16. Yeldandi A, Kaufman DG, Reddy JK. Cell injury and cellular adaptations. In: Damjanov I, Linder J (eds). Anderson's pathology, 10th edn. Mosby: St Louis, Missouri, 1996, pp 357-386.
17. Lord SJ, Rajotte RV, Korbutt GS, et al. Granzyme B: a natural born killer. Immunol Rev 2003;193:31-38.
18. Kam CM, Hudig D, Powers JC. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000;1477:307-323.
19. Gobeil S, Boucher CC, Nadeau D, et al. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 2001;8:588-594.
20. Gorak-Stolinska P, Truman JP, Kemeny DM, et al. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha. J Leukoc Biol 2001;70:756-766.
21. Atkinson EA, Barry M, Darmon AJ, et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem 1998;273:21261-21266.
22. Ida H, Nakashima T, Kedersha NL, Yamasaki S, et al. Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death. Euro J Immunol 2003;33:3284-3292.
23. Janas ML, Groves P, Kienzle N, et al. IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J Immunol 2005;175:8003-8010.
24. Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 2005;106:3090-3096.
25. Ohshima K, Karube K, Hamasaki M, et al. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases. Leuk Lymphoma 2003;44:1367-1378.
26. Ko YH, Cho EY, Kim GE, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology 2004;44:480-489.